Obesity rates are down. Is that because of weight-loss drugs?
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.
Are Weight-Loss Drugs Contributing to a Fall in the Obesity Rate?
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
Lilly to test obesity drugs to treat addiction in 2025
Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said.
Lilly to Test Obesity Drugs to Treat Addiction in 2025, CEO Says
Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said.
What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction
Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster drug as a treatment for alcohol and drug addiction starting next year.
Eli Lilly to test weight loss drugs as addiction treatments
Eli Lilly will launch studies to investigate whether its weight loss medications can help control addictive behaviors such as smoking and alcohol and drug abuse, CEO Dave Ricks revealed in a Dec. 10 interview,
Ro partners with Eli Lilly to expand access to Zepbound vials
Eli Lilly has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug Zepbound. Ro Health is joining other telehealth platforms an
Eli Lilly’s new maneuvers in GLP-1 treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is
Eli Lilly is partnering with Ro to make it easier than ever to get Zepbound
Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound available on telehealth platform Ro. Starting today, consumers can get an online diagnosis,
Swiss Re Says Too Early to Tell if Obesity Drugs Will Reshape Insurance
Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head ...
Obesity overtakes tobacco as health risk, new study shows
Being overweight or obese has overtaken tobacco smoking as the leading risk of disease, new data shows.
STAT16h
Eli Lilly to test obesity medications as treatments for alcohol and drug addiction, CEO says
Eli Lilly will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major ...
Hosted on MSN1h
How RFK Jr. could reverse our nation's foolish approach to obesity
The river was swift and unrelenting, its currents carrying victim after victim downstream. Local villagers responded by ...
Obesity has cost Americans a lot over the past three decades — physically and economically
One study shows two-thirds of Americans are overweight or obese, but better access to health care and health technology could ...
Ibj.com1d
Lilly CEO predicts obesity-treatment Zepbound will become drugmaker’s top drug by 2025
David Ricks told a lunch audience at the Economic Club of Washington, D.C., that Zepbound could quickly become the most ...
Psychology Today6d
A Second Look at Obesity as a Disease
There are moments in time when intellect, emotion, and behavior need to come together, allowing lifestyle intelligence to ...
New Atlas3d
Breakthrough natural micropill targets obesity, diabetes and inflammation
An innovative combination of readily available natural products has shaped up to be an alternative to drugs like Ozempic to ...
Ibj.com1d
Lilly to test obesity drugs for addiction treatment, CEO says
The company also raised its quarterly dividend 15% amid rapid growth fueled in part by the blockbuster weight-loss drug ...
Calgary Herald on MSN18hOpinion
Ford: If obesity is a disease, promoting the cause of it has to stop
Why allow the very highly caloric, not-very-nutritious food tempt those into thus encouraging the disease? We are incessantly ...